The NCCN’s guidelines recommend adding immune checkpoint inhibitors in advanced esophageal and gastric cancers in patients with a PD-L1 combined positive score (CPS) of at least 1 but only give a category 1 preference if the CPS is 5 or…
Considering Role of PD-L1 CPS in Frontline Gastric Cancer Treatment | Targeted Oncology
